Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: Thure Meyer who wrote (929)	3/24/1999 9:09:00 PM
From: vestor	Read Replies (1) \| Respond to of 1837

HEARD THE NEWS...... Assuming 20 % market share what does that translate to as earnings per share..... I am hearing $12. a share.... Agree ? Disagree ? The last time as an anticipated generic the shre price shot up to $25. and DRMD had less of a business...... Am considering limit buy at the open. Does limit $10. make sense ?

To: Thure Meyer who wrote (929)	3/24/1999 9:55:00 PM
From: Doug Bean	Respond to of 1837

Thure: YES!!!!!!!!!!! and yes I did hold my position all along :-))))) can hardly type so nervous. My good buddy who has a ton of it ( 12,200 shares) !! just called screaming in my ear ,, it took me a minute to understand that it was a go for Cenestin. this is HUGE :-))))))))))))) I know it will gap up big time . A limit order to buy more ?? damn who knows.. You won't be able to buy it reasonably for a bit. Geez ,, congratulations to all of you who held on , i hope you make a ton o cash... HOT DAMN!!!! CRDoug